Inventor
FISCHER JOHN P
US23 patents
⚠️ This page may combine multiple inventors who share the name “FISCHER JOHN P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MIRATI THERAPEUTICS INC
6 patentsUS10125134B2Nov 13, 2018
KRas G12C inhibitors
MIRATI THERAPEUTICS INC43 citations96
US10689377B2Jun 23, 2020
KRas G12C inhibitors
MIRATI THERAPEUTICS INC16 citations85
US11267812B2Mar 8, 2022
KRAS G12C inhibitors
MIRATI THERAPEUTICS INC11 citations84
US10633381B2Apr 28, 2020
KRas G12C inhibitors
MIRATI THERAPEUTICS INC8 citations82
US11932633B2Mar 19, 2024
KRas G12C inhibitors
MIRATI THERAPEUTICS INC2 citations71
US11548888B2Jan 10, 2023
KRas G12C inhibitors
MIRATI THERAPEUTICS INC1 citations62
ARRAY BIOPHARMA INC
6 patentsUS10730880B2Aug 4, 2020
4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors
ARRAY BIOPHARMA INC4 citations71
US10189845B2Jan 29, 2019
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
ARRAY BIOPHARMA INC2 citations71
US11634417B2Apr 25, 2023
Protein tyrosine phosphatase inhibitors
ARRAY BIOPHARMA INC2 citations70
US11028093B2Jun 8, 2021
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
ARRAY BIOPHARMA INC0 citations61
US11884664B2Jan 30, 2024
Protein tyrosine phosphatase inhibitors
ARRAY BIOPHARMA INC0 citations59
US9079890B2Jul 14, 2015
Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives
ARRAY BIOPHARMA INC0 citations51
AICHER THOMAS DANIEL
3 patentsUS8212045B2Jul 3, 2012
Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
AICHER THOMAS DANIEL4 citations60
US8853409B2Oct 7, 2014
Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
AICHER THOMAS DANIEL1 citations50
US8754226B2Jun 17, 2014
Piperidinyl-substituted lactams as GPR119 modulators
AICHER THOMAS DANIEL0 citations37